UroGen Pharma Ltd. (URGN) Insider Trading

Name: UroGen Pharma Ltd. (URGN) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 9, 2026): Schoenberg Mark (Chief Medical Officer): Exercise/Conversion of 1,667 shares.

Get alerted when insiders trade URGN

Email address

Loading company data...

Beta

Loading company details...

Beta